ngµç×ÓÓÎÏ·

05

¿ÆÑÐÏ£Íû

ÖÐɽҽѧԺ³Â¿¡½ÌÊÚÍŶӺÍÁ¥ÊôµÚÎåÒ½Ôº³ÂÊØµÇÑо¿Ô±¿ÎÌâ×éÏàÖú·¢Ã÷ÐÂÐ͹Ú×´²¡¶¾£¨SARS-CoV-2£©ORF7aÂѰ׽ṹÓëÃâÒßµ÷Àíй¦Ð§

¸å¼þȪԴ£ºÖÐɽҽѧԺ ÔĶÁÁ¿£º

SARS-CoV-2¾ßÓм«Ç¿µÄѬȾÐÔ £¬£¬£¬Ôì³ÉÁËÏÖÔÚCOVID-19È«Çò´óÊ¢ÐС£¡£×èÖ¹2021Äê3ÔÂ14ÈÕ £¬£¬£¬È«ÇòÀÛ¼ÆÈ·Õï119,212,530Àý £¬£¬£¬ÀÛ¼ÆéæÃü2,642,612Àý¡£¡£Æ¾Ö¤ÒÑÓб¨µÀ £¬£¬£¬»úÌåµÄÃâÒß¹¦Ð§Ê§µ÷ÓëCOVID-19¼²²¡Ï£ÍûÇ×½üÏà¹Ø¡£¡£ÖØÖ¢COVID-19»¼ÕßÌåÄڻᱬ·¢Ç¿¾¢µÄϸ°ûÒò×ӷ籩 £¬£¬£¬¿ÉÊÇ £¬£¬£¬»úÌå¾­³£²»¿É±¬·¢±£»£»£»¤ÐÔµÄ˳ӦÐÔÃâÒß·´Ó³ £¬£¬£¬ÌØÊâÊÇǷȱÓÐÓõIJ¡¶¾ÖкͿ¹Ìå¡£¡£È»¶ø £¬£¬£¬Ñ¬È¾Àú³ÌÖÐSARS-CoV-2²¡¶¾Òò×Óµ÷¿ØÃâÒß¹¦Ð§Ê§ºâµÄÏêϸ·Ö×Ó»úÖÆÏÖÔÚÉв»Ã÷È·¡£¡£

¿ËÈÕ £¬£¬£¬ngµç×ÓÓÎÏ·ÖÐɽҽѧԺ³Â¿¡¿ÎÌâ×éÓëngµç×ÓÓÎÏ·Á¥ÊôµÚÎåÒ½Ôº³ÂÊØµÇ¿ÎÌâ×éÏàÖú £¬£¬£¬ÆÊÎöÁËSARS-CoV-2 ORF7aÂѰ׵ľ§Ìå½á¹¹ºÍÃâÒßµ÷Àí¹¦Ð§¡£¡£·¢Ã÷ ORF7a´ÙʹCD14+µ¥ºË¾ÞÊÉϸ°ûÉøÍ¸´ÙÑ×ÐÔϸ°ûÒò×Ó £¬£¬£¬Í¬Ê±Ïµ÷CD14+µ¥ºË¾ÞÊÉϸ°ûHLA-DR/DP/DQ·Ö×ӵıí´ï £¬£¬£¬ÒÖÖÆµ¥ºË¾ÞÊÉϸ°ûµÄ¿¹Ô­Ìá³ÊÄÜÁ¦ £¬£¬£¬´Ó¶ø×ÊÖúйڲ¡¶¾µÄÃâÒßÌÓÒÝ¡£¡£ÔÚCOVID-19ѬȾÀú³ÌÖÐ £¬£¬£¬ORF7aÂѰ׿ÉÄÜÆðµ½Òªº¦×÷Óᣡ£

¸ÃÏàÖúÍŶÓÊ״η¢Ã÷SARS-CoV-2 ORF7aÄÜÓëÈËÍâÖÜѪµ¥ºËÑùϸ°û£¨PBMC£©ÖеÄCD14+µ¥ºË¾ÞÊÉϸ°û¸ßЧÁ¬Ïµ¡£¡£Í¬Ê± £¬£¬£¬Ê¹ÓÃXÉäÏßµ¥¾§ÑÜÉäÒªÁì £¬£¬£¬Ê״ᨵÀÁËSARS-CoV-2 ORF7a²¡¶¾ÂѰ×2.20 ?µÄ¸ß·Ö±æÂʾ§Ìå½á¹¹¡£¡£Í¨¹ýÓëSARS-CoV ORF7a²¡¶¾ÂѰ׾ÙÐнṹ±È¶ÔÆÊÎö £¬£¬£¬·¢Ã÷SARS-CoV-2 ORF7aµÄ±äÒì°±»ùËáλµã¼¯ÖÐÂþÑÜÓڽϴóµÄһƬ¦ÂƬ²ãÇÒ²àÁ´¾ù³¯ÏòÍâ³ö £¬£¬£¬SARS-CoV-2 ORF7a¿É¼¤»îÈËCD14+µ¥ºË¾ÞÊÉϸ°ûÉøÍ¸´ó×Ú´ÙÑ×ÐÔϸ°ûÒò×Ó £¬£¬£¬°üÀ¨IL-6¡¢IL-1b¡¢IL-8ºÍTNF-aµÈ¡£¡£ ÌáÐÑÕâÊǸò¡¶¾ÂѰ׵ÄDZÔÚ¹¦Ð§½çÃæ¡£¡£

¸üÖ÷ÒªµÄÊÇ £¬£¬£¬¸ÃÑо¿·¢Ã÷ÊÇORF7aÄܹ»ÏÔÖøÏµ÷ÈËCD14+µ¥ºË¾ÞÊÉϸ°ûHLA-DR/DP/DQ·Ö×ӵıí´ï £¬£¬£¬ËµÃ÷SARS-CoV-2 ORF7a»áÒÖÖÆµ¥ºË¾ÞÊÉϸ°ûµÄ¿¹Ô­Ìá³ÊÄÜÁ¦¡£¡£ÕâºÜºÃµØÚ¹ÊÍÁËÁÙ´²ÉÏйڷÎÑ×»¼ÕßµÄÃâÒßÄæ¾³£º¼´»¼Õß¾ßÓÐÇ¿ÁÒµÄÑ×ÐÔ·´Ó³ £¬£¬£¬±¾Ó¦Òý·¢¿¹²¡¶¾µÄ˳ӦÐÔÃâÒßÓ¦´ð¡£¡£µ«ÓÉÓÚORF7aÂѰ׵¼Öµ¥ºË¾ÞÊÉϸ°û²»¿ÉÓÐÓÃÌá³Ê¿¹Ô­ £¬£¬£¬µ¼Ö»úÌåȱ·¦²¡¶¾ÌØÒìÐÔµÄÖкͿ¹Ìå £¬£¬£¬Ï÷ÈõÁË˳ӦÐÔÃâÒß·´Ó³¡£¡£×îºóµ¼ÖÂÑ×ÐÔ·´Ó³³ÉΪÎÞЧµÄϸ°ûÒò×ӷ籩 £¬£¬£¬¹¥»÷»¼ÕßÖ÷ÒªÉúÃüÆ÷¹Ù£¨Èç·Î¡¢ÄԵȣ© £¬£¬£¬½øÒ»²½¼ÓÖØÑ¬È¾¡£¡£¸ÃÊÂÇé¶Ô½øÒ»²½Ã÷È·COVID-19ÖØÖ¢»¼ÕßµÄÃâÒß¹¦Ð§Ê§ºâÓëÏìÓ¦µÄÒ©ÎïÉè¼Æ¿ª·¢¾ßÓÐÖ÷ÒªÖ¸µ¼ÒâÒå¡£¡£

Ê×Ò³|ngµç×ÓÓÎÏ·Öйú¼¯ÍŹٷ½ÍøÕ¾

ͼ. SARS-CoV-2 ORF7a²¡¶¾ÂѰ×ÔÚCOVID-19Ï£ÍûÖе÷ÀíCD14+µ¥ºËϸ°ûÃâÒß·´Ó³Ê§ºâµÄģʽͼ

¸ÃÑо¿Ð§¹û¡°Structural insight reveals SARS-CoV-2 ORF7a as an immunomodulating factor for human CD14+ monocytes¡±¿ËÈÕÔÚiScienceÔÓÖ¾½ÒÏþ¡£¡£ngµç×ÓÓÎÏ·Á¥ÊôµÚÎåÒ½Ôº²©Ê¿ÉúÖÜ×ÓÁÁ¡¢ÖÐɽҽѧԺ²©Ê¿Éú»Æ´ºÁøÓëÁ¥ÊôµÚÎåÒ½Ôº²©Ê¿ÉúÖÜÕÛ³åΪÂÛÎÄÅäºÏµÚÒ»×÷Õß £¬£¬£¬ÖÐɽҽѧԺ³Â¿¡½ÌÊÚÓëÁ¥ÊôµÚÎåÒ½Ôº³ÂÊØµÇÑо¿Ô±ÎªÂÛÎÄÅäºÏͨѶ×÷Õß¡£¡£

Ô­ÎÄÁ´½Ó£ºhttps://www.cell.com/iscience/fulltext/S2589-0042(21)00155-3

¡¾ÍøÕ¾µØÍ¼¡¿